Cargando…
PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
The T-cell inhibitory molecule PD-L1 is expressed on a fraction of breast cancer cells. The distribution of PD-L1 on the different subpopulations of breast cancer cells is not well-defined. Our aim was to study the expression level of PD-L1 on breast cancer stem-like (CSC-like) cells and their diffe...
Autores principales: | Mansour, Fatmah A., Al-Mazrou, Amer, Al-Mohanna, Falah, Al-Alwan, Monther, Ghebeh, Hazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153827/ https://www.ncbi.nlm.nih.gov/pubmed/32313717 http://dx.doi.org/10.1080/2162402X.2020.1729299 |
Ejemplares similares
-
PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
por: Almozyan, Sheema, et al.
Publicado: (2017) -
Higher PD-L1 Immunohistochemical Detection Signal in Frozen Compared to Matched Paraffin-Embedded Formalin-Fixed Tissues
por: Ghebeh, Hazem, et al.
Publicado: (2021) -
Profiling of normal and malignant breast tissue show CD44(high)/CD24(low) phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
por: Ghebeh, Hazem, et al.
Publicado: (2013) -
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
por: Alsuliman, Abdullah, et al.
Publicado: (2015) -
Differential marker expression by cultures rich in mesenchymal stem cells
por: Wetzig, Andrew, et al.
Publicado: (2013)